ATLASIDEXX Laboratories (IDXX) Q3 2026 earnings results
IDEXX Laboratories (IDXX) reported EPS of $4.01 against an analyst estimate of $3.71: a beat of $0.30 (8.1%). The quarter ended Sep 30, 2026; the company reported on Monday, November 2, 2026, before the open.
Status: Confirmed · 17:12 ET, Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when IDEXX Laboratories reports
Track IDXX free Add IDEXX Laboratories to a free ATLAS watchlist.
IDXX Q3 2026 results at a glance
| EPS reported | $4.01 |
|---|---|
| EPS estimate | $3.71 |
| Surprise | Beat · +$0.30 (+8.1%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 2, 2026, before the open |
| Status | Confirmed · 17:12 ET, Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is IDEXX Laboratories’s Q3 2026, a calendar-year company.
IDEXX Laboratories EPS surprise history: last 5 quarters
IDEXX Laboratories beat the EPS estimate in 4 of its last 5 reports, with an average surprise of +6.2%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 2, 2026 | $3.71 | $4.01 | +8.1% | Beat | – |
| Aug 4, 2026 | $3.93 | $4.27 | +8.7% | Beat | +3.0% |
| May 5, 2026 | $3.41 | $3.47 | +1.8% | In line | +2.9% |
| Feb 2, 2026 | $2.94 | $3.08 | +4.8% | Beat | -5.7% |
| Nov 3, 2025 | $3.15 | $3.40 | +7.9% | Beat | +14.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
IDXX stock reaction to the report
IDXX moved +21.88% in the first session that reflects the report (close of Oct 30, 2026 $551.21 to close of Nov 2, 2026 $671.84).
Next IDXX earnings report
IDEXX Laboratories has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the IDXX earnings calendar.
ATLAS fair value and signal for IDXX
| Last price | $661.17 (+20.0%) |
|---|---|
| ATLAS fair value | $329.05 (range $240.73–$449.79) · price is 101% above it |
| Chance of a higher close in 1 month | 51% (normal range $627.61–$698.98) |
These are model outputs from the same valuation and calibrated model as the IDEXX Laboratories stock page. They describe an ordinary period and are not a forecast of any particular outcome.
IDEXX Laboratories Q3 2026 earnings: frequently asked questions
Did IDEXX Laboratories beat earnings estimates for Q3 2026?
IDEXX Laboratories reported EPS of $4.01 against an analyst estimate of $3.71: a beat of $0.30 (8.1%).
When did IDEXX Laboratories report Q3 2026 results?
IDEXX Laboratories reported on Monday, November 2, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does IDXX beat EPS estimates?
In its last 5 reports with a recorded result, IDEXX Laboratories beat the EPS estimate 4 times; the average surprise was +6.2%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer